Replacement Parts After Repair: Compatibility Evidence and Remanufacturing Risk
How clinical engineering teams evaluate replacement parts under FDA's May 2024 remanufacturing guidance, QMSR 21 CFR 820, Figure 1, and CMS return-to-service rules.
By
Topic
spare-parts
Replacement-part identification, control, and lifecycle planning.
MedConsumablesGuide: Tracing an IV Set Change in a Pump Incident
Preserve infusion pump and IV administration set identity across HTM, procurement, and quality after an incident following a set SKU change, before attributing cause or closing the service record.
By